Streetbeat News

Analyst Ratings

SNOW

Deep-pocketed investors are showing a bearish sentiment towards Snowflake (NYSE:SNOW) with significant options activity detected. The stock is currently down by 3.11% and analysts have mixed ratings with an average target price of $168.2.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:47 pm

SPOT

Spotify Technology (NYSE:SPOT) has seen a surge in options activity, with a significant portion being bearish. This unusual activity suggests that large investors anticipate potential changes in SPOT's stock price. Analysts have mixed ratings, with price targets ranging from $340 to $510.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:47 pm

LOW

Deep-pocketed investors are showing a bearish sentiment towards Lowe's Companies (NYSE:LOW) in the options market, with significant options activity detected. The stock is currently down 0.21% at $260.44, and analysts have set an average price target of $265.0. The next earnings report is expected in 60 days.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:47 pm

MELI

Whales are showing a bearish stance on MercadoLibre (NASDAQ:MELI) with 30% of options trades being bearish. The stock is currently trading at $2112.97, with a consensus target price of $2470.0. Analysts maintain positive ratings, but options activity suggests caution.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:33 pm

QCOM

Financial giants are showing a bullish trend on Qualcomm (NASDAQ:QCOM) with 12 unusual options trades, predominantly calls. The predicted price range is $140 to $200. Current trading volume is 5,937,818 with a price of $172.69. Analysts set a price target of $210.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:33 pm

CRBP

NVO

SKYE

Novo Nordisk's phase 2a trial results for monlunabant, a CB1 inverse agonist, showed limited additional weight loss at higher doses, impacting stocks of Corbus Pharmaceuticals and Skye Bioscience. Both companies are developing similar weight loss drugs. Analysts have adjusted price targets for Corbus, and Skye's stock dropped significantly.

Portfolio Pulse from Vandana Singh

September 20, 2024 | 7:18 pm

ABBV

AbbVie (NYSE:ABBV) has seen a surge in options activity, with 8 unusual trades identified. 37% of traders were bullish, and 12% bearish. The options activity suggests a price target range of $165 to $195. The stock is currently trading at $192.86, down 0.39%. An analyst from Piper Sandler maintains an Overweight rating with a target price of $209.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:09 pm

BOKF

Analysts have provided mixed ratings for BOK Financial (NASDAQ:BOKF) over the past three months, with a recent increase in the average 12-month price target to $109.11. The company's financial performance shows strong revenue growth and net margins, but it faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:02 pm

ACHC

Analysts have mixed ratings for Acadia Healthcare Co (NASDAQ:ACHC) with a range of price targets. The company's financials show strong net margins and efficient asset management, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:01 pm

PNFP

Pinnacle Financial Partners (NASDAQ:PNFP) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have raised their 12-month price targets, with an average target of $101.75, up from $95.12. Despite this, the company faces financial challenges, including a decline in revenue and below-industry-average profitability metrics.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 7:01 pm